NCT00151086View on ClinicalTrials.gov

Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

March 31, 2004

Study Completion Date

August 31, 2006

Conditions
Prostate Cancer
Interventions
DRUG

Estramustine

DRUG

Vinorelbine

Trial Locations (1)

48109

The University of Michigan Comprehensive Cancer Center, Ann Arbor

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Michigan Rogel Cancer Center

OTHER